Amphastar Pharmaceuticals, Inc.AMPHNASDAQ
Loading
Operating Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+15.1%
5Y CAGR+10.3%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+15.1%/yr
vs +5.2%/yr prior
5Y CAGR
+10.3%/yr
Recent acceleration
Acceleration
+10.0pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.6x
Solid growth
Streak
4 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $215.65M | +28.0% |
| 2024 | $168.44M | +9.3% |
| 2023 | $154.13M | +9.0% |
| 2022 | $141.36M | +8.9% |
| 2021 | $129.85M | -1.9% |
| 2020 | $132.39M | +0.3% |
| 2019 | $131.96M | +14.1% |
| 2018 | $115.61M | +22.6% |
| 2017 | $94.33M | +6.6% |
| 2016 | $88.50M | - |